Meningitis News and Research

RSS
Meningitis is an infection of the fluid of a person's spinal cord and the fluid that surrounds the brain. People sometimes refer to it as spinal meningitis. Meningitis is usually caused by a viral or bacterial infection. Knowing whether meningitis is caused by a virus or bacterium is important because the severity of illness and the treatment differ. Viral meningitis is generally less severe and resolves without specific treatment, while bacterial meningitis can be quite severe and may result in brain damage, hearing loss, or learning disability. For bacterial meningitis, it is also important to know which type of bacteria is causing the meningitis because antibiotics can prevent some types from spreading and infecting other people. Before the 1990s, Haemophilus influenzae type b (Hib) was the leading cause of bacterial meningitis, but new vaccines being given to all children as part of their routine immunizations have reduced the occurrence of invasive disease due to H. influenzae. Today, Streptococcus pneumoniae and Neisseria meningitidis are the leading causes of bacterial meningitis.
New bacteria discovered in the blood of human patients

New bacteria discovered in the blood of human patients

Universal meningitis vaccination for college students may be too costly, study suggests

Universal meningitis vaccination for college students may be too costly, study suggests

Meningococcal bacteria with antibiotic resistance are at risk of increasing worldwide

Meningococcal bacteria with antibiotic resistance are at risk of increasing worldwide

Researchers use new methods to optimize treatments for tuberculosis meningitis

Researchers use new methods to optimize treatments for tuberculosis meningitis

Clearer diagnosis of polio-like illness in young children

Clearer diagnosis of polio-like illness in young children

New study launched in Burkina Faso to test typhoid conjugate vaccine

New study launched in Burkina Faso to test typhoid conjugate vaccine

Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows

Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Breakthrough research reveals how deadly pneumococcus avoids immune defenses

Study shows how pneumococci challenge the immune system

Study shows how pneumococci challenge the immune system

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

Scientists move closer to gonorrhea vaccine after large-scale proteomic study

Innovative computer software sheds new light on genetic processes underlying deadly diseases

Innovative computer software sheds new light on genetic processes underlying deadly diseases

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

Penn scientists to explore new approach for predicting and treating diseases at individual level

Penn scientists to explore new approach for predicting and treating diseases at individual level

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Most parents aren't able to recognize meningitis until it's too late

Most parents aren't able to recognize meningitis until it's too late

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB